Disclosures: No author besides those listed below has any conflict of interest or received funds from any private or public agency. Giovanni Manfredi has received honoraria from Lilly, Astazeneca, Janssen, and Pfizer; Roberto Tatarelli has participated in Advisory Boards for Schering, Servier, and Pfizer and received honoraria from Schering, Servier, and Pfizer.
Persistent interferon-β-1b-induced psychosis in a patient with multiple sclerosis
Version of Record online: 28 SEP 2010
© 2010 The Authors. Psychiatry and Clinical Neurosciences © 2010 Japanese Society of Psychiatry and Neurology
Psychiatry and Clinical Neurosciences
Volume 64, Issue 5, pages 584–586, October 2010
How to Cite
Manfredi, G., Kotzalidis, G. D., Sani, G., Koukopoulos, A. E., Savoja, V., Lazanio, S., Girardi, N. and Tatarelli, R. (2010), Persistent interferon-β-1b-induced psychosis in a patient with multiple sclerosis. Psychiatry and Clinical Neurosciences, 64: 584–586. doi: 10.1111/j.1440-1819.2010.02122.x
The patient provided written informed consent for the publication of his case.
- Issue online: 28 SEP 2010
- Version of Record online: 28 SEP 2010
- Received 12 February 2010; revised 8 May 2010; accepted 26 June 2010.